美股異動|愛立信盤前升超8.7% Q2銷售額及經調整EBIT均勝預期
愛立信(ERIC.US)美股盤前升8.76%,報6.95美元,開盤後股價勢將創下近兩年新高。消息面上,愛立信公佈第二季業績,淨銷售按年跌7%至598億瑞典克朗,高於市場預期的585億瑞典克朗;捌除減值影響,季度經調整EBIT按年升14%至32.3億瑞典克朗,高於市場預期的27億瑞典克朗。儘管全球多數市場對5G設備的需求不振,但北美市場14%的增長為整體業績提供了一定支撐。愛立信報吿了76億瑞典克朗的自由現金流,在併購前的基礎上實現了環比增長。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.